Answers are grounded in this paper and cite their sources.
Neuropathic pain is a debilitating form of chronic pain that affects 6.9-10% of the population. Health-related quality-of-life is impeded by neuropathic pain, which not only includes physical impairment, but the mental wellbeing of the patient is also hindered. A reduction in both physical and mental wellbeing bares economic costs that need to be accounted for. A variety of medications are in use for the treatment of neuropathic pain, such as calcium channel α2δagonists, serotonin/noradrenaline reuptake inhibitors and tricyclic antidepressants.
No takes yet. Share an insight, caveat, or question.
Hana et al. (2018) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: